STAT, June 19, 2017. Trump’s team is reportedly considering moves that would do little to address the problem — and would instead please the pharmaceutical industry.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Why Are So Many American Women Having Mastectomies?
Our Bodies Ourselves, June 16, 2017. Breast cancer experts believe that many women undergoing mastectomies do not need them and are getting them out of fear, not because of the actual risks.
Read More »Will a New FDA User Fee Discourage Medical Device Innovation?
Bloomberg June 12, 2017: The NCHR is warning that a new FDA user fee could make the de novo pathway more appealing by speeding up device reviews, but at the cost of safety. NCHR says this fast-track process often skips clinical trials and lacks solid scientific proof, putting patients at risk.
Read More »FDA Questions Effect of Abuse-Deterrent Opioids
June 13 2017: The NCHR cautions that opioids labeled as “abuse-deterrent” might not actually stop misuse and can still be abused, giving a false sense of safety. They urge the FDA to ensure that such labels accurately reflect the risks to protect patients from harm.
Read More »Misplaced Trust: Why FDA Approval Doesn’t Guarantee Drug Safety
Drugwatch May 8 2017: Many people think FDA-approved drugs are always safe, but that’s not true. This article explains how some medicines get approved too quickly, why drug companies have a big say in the process, and how patients can protect themselves by asking the right questions.
Read More »